The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults (Q43462235)
Jump to navigation
Jump to search
scientific article published in August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults |
scientific article published in August 2002 |
Statements
1 reference
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults (English)
1 reference
Javier Garau
1 reference
Patrick Petitpretz
1 reference
Christian Chidiac
1 reference
Francisco Soriano
1 reference
Katharine Stevenson
1 reference
Elisabeth Rouffiac
1 reference
556 Clinical Study Group
1 reference
1 August 2002
1 reference
1 reference
Identifiers
1 reference